These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1919204)

  • 1. [Blood component transfusion therapy].
    Takahashi K; Juji T
    Nihon Naika Gakkai Zasshi; 1991 Jun; 80(6):897-901. PubMed ID: 1919204
    [No Abstract]   [Full Text] [Related]  

  • 2. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
    Levy L; Woodfield DG
    N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor availability for platelet transfusion support of alloimmunized thrombocytopenic patients.
    Duquesnoy RJ; Vieira J; Aster RH
    Transplant Proc; 1977 Mar; 9(1):519-21. PubMed ID: 867500
    [No Abstract]   [Full Text] [Related]  

  • 4. [Blood transfusion and blood-derived products transfusion. Immunologic principles and indications].
    Lamy B; Morel P; Hervé P
    Rev Prat; 1998 Mar; 48(5):549-53. PubMed ID: 9781121
    [No Abstract]   [Full Text] [Related]  

  • 5. Donor selection in platelet transfusion therapy of alloimmunized thrombocytopenic patients.
    Duqesnoy RJ
    Prog Clin Biol Res; 1978; 28():229-43. PubMed ID: 88057
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of HLA-C matching in histocompatible platelet transfusion therapy of alloimmunized thrombocytopenic patients.
    Duquesnoy RJ; Filip DJ; Tomasulo PA; Aster RH
    Transplant Proc; 1977 Dec; 9(4):1827-8. PubMed ID: 601843
    [No Abstract]   [Full Text] [Related]  

  • 7. [Transfusion of platelet concentrates].
    Rieux C; Lee K; Lavaud A; Bierling P
    Ann Med Interne (Paris); 1999 Dec; 150(8):631-41. PubMed ID: 10686645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet replacement therapy: a clinical assessment.
    Hester JP; McCredie KB; Freireich EJ
    Prog Clin Biol Res; 1978; 28():281-93. PubMed ID: 752154
    [No Abstract]   [Full Text] [Related]  

  • 9. Establishment of platelet donor registry improves the treatment of platelet transfusion refractoriness in Guangzhou region of China.
    Xia WJ; Ye X; Tian LW; Xu XZ; Chen YK; Luo GP; Bei CH; Deng J; Santoso S; Fu YS
    Transfus Med; 2010 Aug; 20(4):269-74. PubMed ID: 20136782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfusion therapy of refractory thrombcytopenic patients with platelets from donors selectively mismatched for cross-reactive HLA antigens.
    Duquesnay RJ; Filip DJ; Rodey GE; Aster RH
    Transplant Proc; 1977 Mar; 9(1 Suppl 1):221-4. PubMed ID: 854965
    [No Abstract]   [Full Text] [Related]  

  • 11. Variable expression of w4 and w6 on platelets: possible relevance to platelet transfusion therapy of alloimmunized thrombocytopenic patients.
    Duquesnoy RJ; Testin J; Aster RH
    Transplant Proc; 1977 Dec; 9(4):1829-31. PubMed ID: 601844
    [No Abstract]   [Full Text] [Related]  

  • 12. Sounding board: Platelet transfusions from single donors.
    Schiffer CA; Slichter SJ
    N Engl J Med; 1982 Jul; 307(4):245-8. PubMed ID: 7088074
    [No Abstract]   [Full Text] [Related]  

  • 13. Refractory response to platelet transfusion therapy.
    Eisenberg S
    J Infus Nurs; 2010; 33(2):89-97. PubMed ID: 20228646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practice Guidelines for blood component therapy: A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy.
    Anesthesiology; 1996 Mar; 84(3):732-47. PubMed ID: 8659805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet transfusions to HLA-immunized recipients: how to be or not to be matched.
    Rubinstein P
    Transfusion; 2010 Nov; 50(11):2292-4. PubMed ID: 21182628
    [No Abstract]   [Full Text] [Related]  

  • 16. Refractory thrombocytopenia and positive platelet crossmatches without HLA or platelet-specific antibodies.
    Kankirawatana S; Huang ST; Arndt DW; Marques MB
    Am J Hematol; 2007 Feb; 82(2):175-6. PubMed ID: 16924652
    [No Abstract]   [Full Text] [Related]  

  • 17. HLA class II antibodies in transfusion-related acute lung injury (TRALI). A case report.
    Lydaki E; Bolonaki E; Nikoloudi E; Chalkiadakis E; Iniotaki-Theodoraki A
    Transfus Apher Sci; 2005 Oct; 33(2):107-11. PubMed ID: 16115801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunological support of component blood transfusion therapy].
    Shablin VN; Serova LD; Abdulkadyrov KM; Mel'nikova VN
    Probl Gematol Pereliv Krovi; 1978 Aug; 23(8):3-7. PubMed ID: 683985
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical aspects of platelet transfusion].
    Julia A; Massuet L; Pujol M; Martín Vega C
    Sangre (Barc); 1985; 30(4-B):548-56. PubMed ID: 3909466
    [No Abstract]   [Full Text] [Related]  

  • 20. Platelet transfusion therapy.
    AuBuchon JP
    Clin Lab Med; 1996 Dec; 16(4):797-816. PubMed ID: 8974196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.